Top Headlines

Catalent unveils ulta-sensitive melamine test for drugs

US contract services firm Catalent has launched a new test service capable of detecting trace amounts of the toxic chemical melamine in pharmaceuticals.

Abraxis dedicates nanobiologics site

Abraxis Health has dedicated its manufacturing facility in Phoenix, Arizona, US which is the result of a $70m (€47m) investment to give the company the nanotech and biologics capacity needed for Abraxane production.

PharmaForm rolls out contract spray-drying service

US CMO PharmaForm has added spray-drying to its contract offering to capture a share of the ever-present market for drug bioavailability enhancement.

SMS deal expands reach

Particulate Systems (PS) and Surface Measurement Systems (SMS) have entered into a strategic collaboration drawing on their knowledge of using analytic equipment for the characterisation of particulate, porous and complex materials.

Genzyme targets BBB

Genzyme is evaluating to-BBB’s G-Technology as part of a research collaboration aimed at developing treatments capable of crossing the blood-brain barrier (BBB).

News in brief

Today's headlines across the Pharmaceutical industry

CTI buys German research staffing firm CRS from Outsourcing-Pharma.com

Ohio, US-based CTI Clinical Trial and Consulting Services (CTI) has bought German trial staffing specialist CRS Clinical Research Services (CRS) to build its presence in Europe’s contract research sector.

Lonza buys into immunogenicity from Outsourcing-Pharma.com

Lonza has bolstered its protein design capabilities by acquiring Algonomics, a CRO with technologies which predict immunogenicity to improve development of protein therapeutics and vaccines.

News in brief

Shire extends Medidata trial management contract from Outsourcing-Pharma.com

Medidata Solutions has won a multi-year extension to its benchmarking and analysis contract with drugmaker Shire.

PharmaNet and Phase Forward sign EDC deal from Outsourcing-Pharma.com

PharmaNet will offer Phase Forward’s InForm EDC and trial management platform to customers under a new deal announced today.

On your radar